Burn and smoke injury activates poly(adp-ribose)polymerase in circulating leukocytes

Shock

Volumn 36, Issue 2, 2011, Pages 144-148

  Bartha, Eva ^a   Asmussen, Sven ^a   Olah, Gabor ^a   Rehberg, Sebastian W ^a   Yamamoto, Yusuke ^a   Traber, Daniel L ^a   Szabo, Csaba ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Burn injury; leukocytes; poly(ADP ribose)polymerase; smoke injury

Indexed keywords

N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

ANESTHESIA LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BURN; CELL ISOLATION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HISTOPAQUE METHOD; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LUNG BURN; NONHUMAN; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; SHEEP; VENOUS BLOOD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BURNS; FEMALE; LEUKOCYTES; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES; SHEEP; SMOKE;

EID: 80051545415     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318212988c     Document Type: Article

References (41)

1. Herndon D, ed. Total Burn Care. Philadelphia: Saunders, 2007.
2. Colohan SM: Predicting prognosis in thermal burns with associated inhalational injury: a systematic review of prognostic factors in adult burn victims. J Burn Care Res 31(4):529-539, 2010.
3. O'Sullivan ST, O'Connor TP: Immunosuppression following thermal injury: the pathogenesis of immunodysfunction. Br J Plast Surg 50(8):615-623, 1997. (Pubitemid 28026543)
4. Enkhbaatar P, Traber DL: Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 107(2):137-143, 2004. (Pubitemid 39070929)
5. Sterner JB, Zanders TB, Morris MJ, Cancio LC: Inflammatory mediators in smoke inhalation injury. Inflamm Allergy Drug Targets 8(1):63-69, 2009.
6. Latenser BA: Critical care of the burn patient: the first 48 hours. Crit Care Med 37(10):2819-2826, 2009.
7. Mayers I, Johnson D: The nonspecific inflammatory response to injury. Can J Anaesth 45(9):871-879, 1998. (Pubitemid 29014236)
8. Latha B, Babu M: The involvement of free radicals in burn injury: a review. Burns 27(4):309-317, 2001. (Pubitemid 32451669)
9. Horton JW: Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 189(1-2):75-88, 2003. (Pubitemid 36725024)
10. Roth E, Manhart N, Wessner B: Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 7(2):161-168, 2004. (Pubitemid 40340679)
11. Maldonado MD, Murillo-Cabezas F, Calvo JR, Lardone PJ, Tan DX, Guerrero JM, Reiter RJ: Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage. Crit Care Med 35(4):177-185, 2007.
12. Parihar A, Parihar MS, Milner S, Bhat S: Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34(1):6-17, 2008.
13. Berger MM: Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 21(5):438-449, 2006. (Pubitemid 44497057)
14. Pham TN, Cancio LC, Gibran NS, American Burn Association: American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res 29(1):257-266, 2008.
15. Shenkin A: Selenium in intravenous nutrition. Gastroenterology 137(Suppl 5):S61-S69, 2009.
16. Wolf SE: Vitamin C and smoke inhalation injury. J Burn Care Res 30(1): 184-186, 2009.
17. Traber DL, Traber MG, Enkhbaatar P, Herndon DN: Tocopherol as treatment for lung injury associated with burn and smoke inhalation. J Burn Care Res 30(1):164-165, 2009.
18. Jagtap P, Szabo C: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4(5):421-440, 2005. (Pubitemid 40704125)
19. Pacher P, Szabo C: Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173(1):2-13, 2008. (Pubitemid 351947950)
20. Peralta-Leal A, Rodríguez-Vargas JM, Aguilar-Quesada R, Rodríguez MI, Linares JL, de Almodóvar MR, Oliver FJ: PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radic Biol Med 47(1): 13-26, 2009.
21. Avlan D, Takinlar H, Unlü A, Oztürk C, Cinel L, Nayci A, Cinel I, Aksöyek S: The role of poly(ADP-ribose) synthetase inhibition on the intestinal mucosal barrier after thermal injury. Burns 30(8):785-792, 2004. (Pubitemid 39536044)
22. Avlan D, Unlü A, Ayaz L, Camdeviren H, Nayci A, Aksöyek S: Poly (ADPribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury. Pediatr Surg Int 21(6):449-455, 2005. (Pubitemid 40931914)
23. Liaudet L, Pacher P, Mabley JG, Virág L, Soriano FG, Haskó G, Szabo C: Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 165(3):372-377, 2002. (Pubitemid 34118511)
24. Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabo C, et al.: Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 285(1):L240-L249, 2003. (Pubitemid 36736487)
25. Murthy KG, Xiao CY, Mabley JG, Chen M, Szabo C: Activation of poly(ADPribose) polymerase in circulating leukocytes during myocardial infarction. Shock 21(3):230-234, 2004.
26. Tóth-Zsámboki E, Horváth E, Vargova K, Pankotai E, Murthy K, Zsengellér Z, Bárány T, Pék T, Fekete K, Kiss RG, et al.: Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol Med 12(9-10):221-228, 2006. (Pubitemid 44925021)
27. Mabley JG, Horváth EM, Murthy KG, Zsengellér Z, Vaslin A, Benko R, Kollai M, Szabo C: Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J Pharmacol Exp Ther 315(2):812-820, 2005. (Pubitemid 41500748)
28. Horváth EM, Benko R, Gero D, Kiss L, Szabo C: Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia. Life Sci 82(3-4):205-209, 2008.
29. Horváth EM, Benko R, Kiss L, Murányi M, Pék T, Fekete K, Bárány T, Somlai A, Csordás A, Szabo C: Rapid Fglycaemic swings induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia 52(5):952-961, 2009.
30. Horváth EM, Magenheim R, Kugler E, Vácz G, Szigethy A, Lévárdi F, Kollai M, Szabo C, Lacza Z: Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia 52(9): 1935-1943, 2009.
31. Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F Jr, et al.: Novel phenanthridinone inhibitors of poly (adenosine 5¶-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 30(5):1071-1082, 2002. (Pubitemid 34508031)
32. Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL, Szabo C: Effect of Lbuthionine-( S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite-and endotoxic shockYinduced vascular failure. Br J Pharmacol 123(3):525-537, 1998. (Pubitemid 28059722)
33. Szabo C, Ischiropoulos H, Radi R: Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6(8):662-680, 2007. (Pubitemid 47207751)
34. Liaudet L, Szabo A, Soriano FG, Zingarelli B, Szabo C, Salzman AL: Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14(2):134-141, 2000.
35. Szabo G, Soós P, Mandera S, Heger U, Flechtenmacher C, Seres L, Zsengellér Z, Sack FU, Szabo C, Hagl S: Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5¶-diphosphate-ribose) polymerase. Crit Care Med 32(12):2392-2397, 2004. (Pubitemid 39648218)
36. Ghani QP, Hollenberg M: Poly(adenosine dephosphate ribose) metabolism and regulation of myocardial cell growth by oxygen. Biochem J 170(2): 387-394, 1978. (Pubitemid 8270815)
37. Zingarelli B, Salzman AL, Szabo C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83(1):85-94, 1998. (Pubitemid 28322102)
38. Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, Esposito K, Szabo C, Ceriello A: Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2(8):1453-1459, 2004. (Pubitemid 40186145)
39. Haddad M, Rhinn H, Bloquel C, Coqueran B, Szabo C, Plotkine M, Scherman D, Margaill I: Anti-inflammatory effects of PJ34, a poly(ADPribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 149(1):23-30, 2006. (Pubitemid 44299065)
40. Virág L, Salzman AL, Szabo C: Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161(7):3753-3759, 1998.
41. Wang Y, Dawson VL, Dawson TM: Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 218(2):193-202, 2009.